Soligenix SNGX
NASDAQ SNGX
$0.38 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Soligenix (SNGX) EPS (Diluted) (2013 - 2026)

Soligenix (SNGX) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.23
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.33
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.19
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.15
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Soligenix 6.06 Mn 6.06 Mn - -0.12

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.12
Mar 31, 2026 -0.28
Dec 31, 2025 -0.56
Sep 30, 2025 -0.58
Jun 30, 2025 -0.82
Mar 31, 2025 -0.97
Dec 31, 2024 -1.80
Sep 30, 2024 -0.78
Jun 30, 2024 -1.31
Mar 31, 2024 -2.91
Dec 31, 2023 -3.75
Sep 30, 2023 -2.56
Jun 30, 2023 -3.56
Mar 31, 2023 -5.74
Dec 31, 2022 -20.92
Sep 30, 2022 -18.43
Jun 30, 2022 -13.32
Mar 31, 2022 -24.32
Dec 31, 2021 -28.13
Sep 30, 2021 -21.16